Lung Cancer Outcomes May Be Improved By Chemo With TKI Drug
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with
Everything about lung cancer is here.
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with
A new study has been conducted by investigators from the Mass General Cancer Center in collaboration with researchers at the
The researchers from Okayama University in Japan have found evidence that ingesting juice from sarunashi fruit can help prevent and
The disease of lung cancer is a significant health concern all around the world. Its alarming rise is becoming serious
The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated